Metraipolis › archive › dc_d1cbb5231e34

Sotagliflozin Modulation of SIRT1/Nrf2 and PI3K/AKT Signaling Pathway Ameliorates Experimental Liver Fibrosis in Rats — Europe PMC PMID:41498016

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41498016
DOI
10.1155/omcl/7684652
License (as archived)
solo-consultazione
Archived
2026-11-07T11:21:18.608Z
SHA-256 of the archived text
c83b1b74f8661e19e0f44be65fd2e5a67e8b857000ac2f5c14540b5a4cc1b40e
Stable URL of this page
https://metraipolis.com/documento/dc_d1cbb5231e34

How to cite

Sotagliflozin Modulation of SIRT1/Nrf2 and PI3K/AKT Signaling Pathway Ameliorates Experimental Liver Fibrosis in Rats — Europe PMC PMID:41498016 — Europe PMC (en), https://europepmc.org/article/MED/41498016 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d1cbb5231e34 (Metraipolis archive dc_d1cbb5231e34, sha256 c83b1b74f8661e19e0f44be65fd2e5a67e8b857000ac2f5c14540b5a4cc1b40e)
BibTeX
@misc{dcd1cbb5231e34,
  title = {Sotagliflozin Modulation of SIRT1/Nrf2 and PI3K/AKT Signaling Pathway Ameliorates Experimental Liver Fibrosis in Rats — Europe PMC PMID:41498016},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41498016},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d1cbb5231e34; sha256 c83b1b74f8661e19e0f44be65fd2e5a67e8b857000ac2f5c14540b5a4cc1b40e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41498016. Agents can read the archived copy with the MCP tool read_document.